Home Psychedelic Stock Review Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright. Biotech NewsInstitutional Analyst NewsletterPsychedelic NewsPsychedelic Stock Review Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright. By Editor / Curator - July 26, 2021 Facebook Twitter Google+ Pinterest Linkedin Email Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT LIVE QUOTE INVESTOR DECK RELATED ARTICLESMORE FROM AUTHOR All News Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC 2025 Watch List GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector. 2025 Watch List Adding Allarity (ALLR) $0.70, to Watch List. 2025 Watch List Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine! All News Vaccine Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD) All News Zomedica (ZOMDF) Surges 40% Higher, Friday. Latest article Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC All News Editor / Curator - April 18, 2025 Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and... GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector. 2025 Watch List Editor / Curator - April 15, 2025 Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the... Adding Allarity (ALLR) $0.70, to Watch List. 2025 Watch List Editor / Curator - April 14, 2025 LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...